CLC Bio Expands Operations in Response to Increased Data Analysis Demands in the Americas | GenomeWeb

CLC Bio announced this week that it has opened two new offices in Boston and in the Washington DC area to meet the increasing demand for its data analysis tools from customers in North and South America.

The company's Boston office officially opened on Sept. 1 and will be a home base for its sales, marketing, and support operations. The DC-based offices will be used as a Government Sector branch.

CLC Bio has also hired several new employees this year and plans to employ additional staff for its US team.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.